KR970001811B1 - 신규의 폴리펩티드 및 그 제조방법 - Google Patents

신규의 폴리펩티드 및 그 제조방법 Download PDF

Info

Publication number
KR970001811B1
KR970001811B1 KR1019890700677A KR890700677A KR970001811B1 KR 970001811 B1 KR970001811 B1 KR 970001811B1 KR 1019890700677 A KR1019890700677 A KR 1019890700677A KR 890700677 A KR890700677 A KR 890700677A KR 970001811 B1 KR970001811 B1 KR 970001811B1
Authority
KR
South Korea
Prior art keywords
polypeptide
arg
cys
lps
general formula
Prior art date
Application number
KR1019890700677A
Other languages
English (en)
Korean (ko)
Other versions
KR890701624A (ko
Inventor
다까노리 나까무라
사다아끼 이와나가
모또노리 오노
교스께 미야자끼
Original Assignee
세이까가꾸 고교 가부시끼가이샤
와따루 야마야
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세이까가꾸 고교 가부시끼가이샤, 와따루 야마야 filed Critical 세이까가꾸 고교 가부시끼가이샤
Publication of KR890701624A publication Critical patent/KR890701624A/ko
Application granted granted Critical
Publication of KR970001811B1 publication Critical patent/KR970001811B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1019890700677A 1987-08-21 1988-08-19 신규의 폴리펩티드 및 그 제조방법 KR970001811B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP206258/1987 1987-08-21
JP20625887 1987-08-21
PCT/JP1988/000823 WO1989001492A1 (fr) 1987-08-21 1988-08-19 Nouveau polypeptide et procede de prepration

Publications (2)

Publication Number Publication Date
KR890701624A KR890701624A (ko) 1989-12-21
KR970001811B1 true KR970001811B1 (ko) 1997-02-15

Family

ID=16520353

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890700677A KR970001811B1 (ko) 1987-08-21 1988-08-19 신규의 폴리펩티드 및 그 제조방법

Country Status (13)

Country Link
US (2) US5068314A (fr)
EP (1) EP0343248B1 (fr)
JP (1) JP2710653B2 (fr)
KR (1) KR970001811B1 (fr)
CN (1) CN1031193C (fr)
AT (1) ATE88480T1 (fr)
AU (1) AU642089B2 (fr)
CA (2) CA1337781C (fr)
DE (1) DE3880481T2 (fr)
DK (1) DK193589A (fr)
FI (1) FI92708C (fr)
NO (2) NO175372C (fr)
WO (1) WO1989001492A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756198C2 (de) * 1996-12-21 2003-03-20 Hyundai Motor Co Ltd Vorrichtung zum Öffnen und Schließen eines Kofferraumdeckels

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (fr) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
ES2081491T3 (es) * 1990-09-11 1996-03-16 Seikagaku Kogyo Co Ltd Nuevo polipeptido y farmaco anti-vih preparado a partir de este polipeptido.
EP0549102B1 (fr) * 1991-12-25 1996-07-03 Maruha Corporation Réactifs et procédés pour déterminer des Beta-Glucanes
JP3361830B2 (ja) * 1992-03-30 2003-01-07 生化学工業株式会社 抗菌性組成物及びそれを有効成分とする薬剤
ATE152734T1 (de) * 1992-05-30 1997-05-15 Sikiric Predrag Bpc-peptide, deren herstellung und verwendung
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
CA2112776C (fr) * 1993-01-21 2002-11-12 Masakazu Tsuchiya Methode pour inhiber l'activite d'une endotoxine
WO1995005393A2 (fr) 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Peptides liant et neturalisant les lipopolysaccharides
CN1038841C (zh) * 1993-10-14 1998-06-24 生化学工业株式会社 新型多肽以及由其制备的抗人类免疫缺陷病毒制剂
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
CN100389140C (zh) * 2006-05-12 2008-05-21 北京理工大学 由聚肽-b-聚四氢呋喃-b-聚肽三嵌段共聚物制备纳米及微米级自组装体的方法
WO2011008863A2 (fr) * 2009-07-14 2011-01-20 Lucia Irene Gonzalez Peptides stéréoisomères et leurs conjugués polymères pour infection par le vih
CN108623659B (zh) * 2018-03-17 2021-09-14 中国海洋大学 一种氨基酸全部选用d型氨基酸的抗菌肽合成方法
WO2021183061A1 (fr) * 2020-03-13 2021-09-16 Vet Products Research And Innovation Center Company Limited Peptides antimicrobiens pour l'inhibition de micro-organismes pathogènes dans les voies digestives et respiratoires chez l'animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663435A (en) * 1982-12-06 1987-05-05 Merck & Co., Inc. Bridged cyclic hexapeptide somatostatin analogs
CA1337781C (fr) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756198C2 (de) * 1996-12-21 2003-03-20 Hyundai Motor Co Ltd Vorrichtung zum Öffnen und Schließen eines Kofferraumdeckels

Also Published As

Publication number Publication date
JPH02500194A (ja) 1990-01-25
NO891572L (no) 1989-05-09
FI92708B (fi) 1994-09-15
KR890701624A (ko) 1989-12-21
DK193589A (da) 1989-06-16
AU620345B2 (en) 1992-02-20
EP0343248A1 (fr) 1989-11-29
FI92708C (fi) 1994-12-27
US5068314A (en) 1991-11-26
NO175372B (no) 1994-06-27
NO175372C (no) 1994-10-05
WO1989001492A1 (fr) 1989-02-23
AU642089B2 (en) 1993-10-07
CA1337781C (fr) 1995-12-19
CA1337782C (fr) 1995-12-19
FI891873A0 (fi) 1989-04-19
EP0343248B1 (fr) 1993-04-21
JP2710653B2 (ja) 1998-02-10
DK193589D0 (da) 1989-04-20
AU1702892A (en) 1992-07-16
CN1031193C (zh) 1996-03-06
NO940078L (no) 1989-05-09
US5416194A (en) 1995-05-16
CN1031379A (zh) 1989-03-01
NO178663B (no) 1996-01-29
DE3880481D1 (de) 1993-05-27
FI891873A (fi) 1989-04-19
DE3880481T2 (de) 1993-09-09
AU2311388A (en) 1989-03-09
NO940078D0 (no) 1994-01-10
ATE88480T1 (de) 1993-05-15
NO178663C (no) 1996-05-08
NO891572D0 (no) 1989-04-18

Similar Documents

Publication Publication Date Title
KR970001811B1 (ko) 신규의 폴리펩티드 및 그 제조방법
Bodanszky et al. Synthesis of secretin. II. Stepwise approach
US5663291A (en) Process for obtaining insulin having correctly linked cystine bridges
Erlanson et al. Purification and characterization of two proteins with co-lipase activity from porcine pancreas
EP0413957A2 (fr) Fragments de la protéine de tensio-actif pulmonaire
EP0025897B1 (fr) Peptides et procédé pour leur préparation
Oliva et al. Marked differences in the ability of distinct protamines to disassemble nucleosomal core particles in vitro
Foster et al. A new, improved technique for automated sequencing of non-polar peptides
US4016258A (en) Vasoactive intestinal peptide from fowl
US5547937A (en) Pulmonary surfactant protein fragments
CA1146166A (fr) Peptides ayant une activite semblable a celle de l'ubiquitine
Vargas et al. Characterization of six toxins from the venom of the Moroccan scorpion Buthus occitanus mardochei
Kondo et al. Primary Structure of the Membrane-Binding Segment of Rabbit Cytochrome b 5
Huberman et al. A neuropeptide with molt-inhibiting hormone activity from the sinus gland of the Mexican crayfish Procambarus bouvieri (Ortmann)
US4290943A (en) Method of preparing polypeptides
Kmiecik et al. Primary structure of histone H2A from nucleated erythrocyte of the marine worm Sipunculus nudus presence of two forms of H2A in the sipunculid chromatin
SE446867B (sv) Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
Wong et al. Synthesis of a fully active snake venom cardiotoxin by fragment condensation on solid polymer
Mohri et al. Comparison of tubulin and actin
AU620345C (en) Novel polypeptide and method for preparing the same
Whittaker et al. Studies on Monotreme Proteins II. Amino Acid Sequence of the a-Chain in Haemoglobin From the Echidna, Tachyglossus Aculeatus Aculeatus
Wu et al. The role of the N-terminal leucine residue in snake venom cardiotoxin II (Naja naja atra)
SE446866B (sv) Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
JP2798711B2 (ja) ポリペプチド系抗ウィルス剤
Schwartz et al. Insulin analog possessing higher in vitro biological activity than receptor binding affinity.[21-Proline-B] insulin

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020206

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee